The advent of minimally invasive technologies to approachliver diseases changed some paradigms of liver surgeryduring the last two decades. They allow to safely
Hepatocellular carcinoma (HCC) occurs at a rate of 3-5%per year in patients with compensated cirrhosis, and itoften represents the first disease complication and